Emelie Svanberg

Associate
  • Stockholm
  • Languages:
    Swedish, English

Practice Areas

Education

  • Uppsala University, LL.M., 2018
  • Vienna University of Business and Economics, exchange semester, 2017
  • University of Victoria, exchange semester, 2016

Mandates

Mandate June 11, 2021

Vinge has advised Sdiptech AB (publ) in connection with its listing on Nasdaq Stockholm

Vinge has advised Sdiptech AB (publ) in connection with its list change from Nasdaq First North Prem…

Mandate April 20, 2020

Vinge has advised CELLINK AB (publ) in connection with its listing on Nasdaq Stockholm

Vinge has advised CELLINK AB (publ) in connection with its list change from Nasdaq First North Growt…

Mandate April 02, 2020

Vinge advises Isofol in conjunction with capital procurement

Vinge has advised Isofol Medical AB (publ), First North Growth Market Premier, in connection with it…

Mandate January 10, 2020

Vinge advises Latour Capital and Sulo on the acquisition of San Sac Group

Sulo is a leading international manufacturer of bins, underground and semi-underground systems for c…

Mandate September 24, 2019

Vinge has advised EQT AB (publ) in connection with the listing on Nasdaq Stockholm

Vinge has advised EQT AB (publ) (“EQT”) in connection with the offering and listing on Nasdaq Stockh…

Mandate September 23, 2019

Vinge advises Vicore Pharma in connection with its listing on Nasdaq Stockholm

Vinge advises Vicore Pharma Holding AB (publ) in connection with its list change from Nasdaq First N…

Mandate February 25, 2019

Vinge advises Vostok New Ventures Ltd

Vinge has advised Vostok New Ventures Ltd with capital markets related questions in light of the com…

Mandate December 04, 2018

Vinge advises Vicore Pharma in connection with a directed share issue

The board of directors of Vicore Pharma has resolved, subject to the approval by an extraordinary ge…